Mrs. Fatemeh Jahanmard – Pharmaceutical Chemistry – Best Researcher Award

Posted on by sciencefather

Mrs. Fatemeh Jahanmard – Pharmaceutical Chemistry – Best Researcher Award

Gilbert – Netherlands

Author Profile

Scopus

Google Scholar

🎓 Academic Background & Expertise

Mrs. Fatemeh Jahanmard Hosseinabadi holds a Ph.D. in Nanotechnology, specializing in formulation development, materials characterization, and drug delivery systems. With extensive expertise in these areas, she has contributed significantly to the advancement of polymeric and lipid-based nano/microparticles, antibacterial coatings, and hydrogel formulations for controlled drug release.

🔬 Postdoctoral Research & Scientific Contributions

She pursued four years of postdoctoral research at Utrecht University, where she developed advanced hydrogel coatings and nanoparticle-based drug delivery systems. Her work focused on innovative materials for biomedical applications, leading to the development of cutting-edge drug delivery platforms. During this time, she also mentored over ten graduate students, led multiple research projects, and managed laboratory operations, showcasing her leadership in academia.

🏥 Industry Leadership & Innovation

Currently serving as an R&D Manager at EHDA and Formulation Scientist at Gilbert, she plays a crucial role in bridging academia and industry. Her expertise in medical devices, biomaterials, coatings, and formulation science has been instrumental in driving innovative formulation strategies. In the industry, she has successfully established a formulation and test development lab, optimized drug delivery systems, and collaborated with engineers, scientists, professors, and regulatory experts to develop a novel inhaler device.

🏆 Bridging Academia & Industry

Her career is defined by her ability to translate research insights into practical applications, fostering innovation in formulation science. By integrating knowledge from both academic research and industrial applications, she continues to drive groundbreaking advancements in drug delivery systems, medical devices, and biomaterial coatings.

Notable Publications📝

📝Layer by Layer Coating for Bio-functionalization of Additively Manufactured Meta-Biomaterials

Authors: S Amin Yavari, M Croes, B Akhavan, F Jahanmard, CC Eigenhuis, Sasan Dadbakhsh, HC Vogely, MM Bilek, AC Fluit, CHE Boel, BCH Van Der Wal, T Vermonden, H Weinans, AA Zadpoor

Journal: Additive Manufacturing

Year: 2020

📝Bactericidal Coating to Prevent Early and Delayed Implant-Related Infections

Authors: F Jahanmard, M Croes, M Castilho, A Majed, MJ Steenbergen, K Lietaert, HC Vogely, BCH Van Der Wal, DAC Stapels, J Malda, T Vermonden, S Amin Yavari

Journal: Journal of Controlled Release

Year: 2020

📝Effect of Nanoporous Fibers on Growth and Proliferation of Cells on Electrospun Poly (ϵ-Caprolactone) Scaffolds

Authors: Fatemeh Jahanmard Hossein Abadi, Mohammad Amani Tehran, Fatemeh Zamani, Marziyeh Nematollahi, Laleh Ghasemi Mobarakeh, Mohammad Hossein Nasr-Esfahani

Journal: International Journal of Polymeric Materials and Polymeric Biomaterials

Year: 2014

📝Controlled Temperature-Mediated Curcumin Release from Magneto-Thermal Nanocarriers to Kill Bone Tumors

Authors: A Khodaei, F Jahanmard, HR Madaah Hosseini, R Bagheri, A Dabbagh, H Weinans, S Amin Yavari

Journal: Bioactive Materials

Year: 2022

📝A Multifunctional Silk Coating on Additively Manufactured Porous Titanium to Prevent Implant-Associated Infection and Stimulate Bone Regeneration

Authors: Z Gorgin Karaji, F Jahanmard, AH Mirzaei, B Van der Wal, S Amin Yavari

Journal: Biomedical Materials

Year: 2020

 

Prof Dr. sonja schrepfer | Pharmaceutical Chemistry | Best Researcher Award

Posted on by sciencefather

Prof Dr. sonja schrepfer | Pharmaceutical Chemistry | Best Researcher Award

Prof Dr. sonja schrepfer | Hypoimmune Platform | United States

Dr. Sonja Schrepfer is a Professor of Surgery at the prestigious University of California, San Francisco (UCSF), where she has held tenure since 2015. She is also an Affiliated Member at the Gladstone-UCSF Institute of Genomic Immunology and the Scientific Founder and Senior Vice President at Sana Biotechnology Inc., heading the revolutionary Hypo-Immune Platform.

Professional Profile

Scopus

👩‍⚕️ Academic and Professional Journey

Dr. Sonja Schrepfer, MD, PhD, is a globally recognized leader in the fields of transplant immunology, stem cell biology, and regenerative medicine. She is a Professor of Surgery at the University of California, San Francisco (UCSF), and an Affiliated Member at the Gladstone-UCSF Institute of Genomic Immunology. In addition, she serves as the Scientific Founder and Senior Vice President at Sana Biotechnology Inc., heading their Hypo-Immune Platform. Dr. Schrepfer has seamlessly blended academia with biotechnology to develop revolutionary approaches to tissue transplantation and immune modulation. Her journey began with an MD degree in 2001 from the University of Würzburg, Germany, followed by a PhD in Immunology in 2007. Over the years, she has held prestigious academic positions at renowned institutions such as Stanford University, University Hamburg, and UCSF, where her work has earned her tenure and global acclaim.

🧪 Research and Innovations

Dr. Sonja Schrepfer is a pioneering figure in the fields of immunology and regenerative medicine, where her work seamlessly integrates scientific discovery with clinical applications. Her research in Pluripotent Stem Cell (PSC) Immunobiology focuses on overcoming the challenges of transplant rejection by exploring immune evasion strategies. Leading transformative studies at UCSF, she has advanced the development of hypo-immunogenic tissues and organs, revolutionizing transplantation outcomes. In transplant immunology, her lab investigates the mechanisms behind acute and chronic graft rejection. By leveraging gene-editing technologies, Dr. Schrepfer is addressing the global organ shortage crisis with innovative solutions, including the creation of safe and effective transplantable human organs.

🏆 Awards and Honors

Dr. Schrepfer’s outstanding contributions to medicine and science have garnered her numerous prestigious accolades. She received the 2022 BWB Biology Breakthrough Award and the 2021 California Life Sciences Pantheon Award, recognizing her groundbreaking advancements. Her earlier achievements include the 2019 Galenus-von-Pergamon Medal in Basic Science Medicine and the 2015 Paul Martini Prize for pioneering cardiovascular therapies. Additionally, her commitment to nurturing the next generation of scientists is reflected in the multiple Mentor Awards she has received from The Transplantation Society.

🧑‍🏫 Teaching and Mentorship

A passionate educator, Dr. Schrepfer has been actively involved in teaching and mentoring students at all academic levels. At UCSF, she plays a key role in the Biomedical Sciences Program and the Medical School Space Medicine curriculum, where her expertise enriches the learning experience. Throughout her career, she has mentored numerous medical fellows, postdoctoral researchers, and undergraduates, fostering a supportive environment that cultivates excellence in both research and clinical practice.

🔬 Main Research Interests

Dr. Schrepfer’s research spans critical areas of biomedical science. Her work in PSC Immunobiology drives advancements in regenerative medicine, particularly through the development of hypo-immunogenic stem cells. In the realm of transplant immunology, she focuses on creating genome-engineered tissues that aim to improve the safety and efficacy of transplantation practices, contributing to transformative progress in healthcare.

🌍 Professional Activities and Leadership

Dr. Schrepfer is an active leader in several prominent international scientific societies, including the American Society of Transplantation, the International Society for Heart and Lung Transplantation, and the International Society for Stem Cell Research (ISSCR). Beyond her membership, she plays key roles in editorial boards and conference committees, where her expertise helps shape the future of these fields on a global scale.

Publications Top Noted📚 

Leukotriene B4: A potential mediator and biomarker for cardiac allograft vasculopathy

Authors: Wang, D., Tediashvili, G., Kim, D., Schrepfer, S., Khush, K.K.

Journal: Journal of Heart and Lung Transplantation

Year: 2024

Hypoimmune islets achieve insulin independence after allogeneic transplantation in a fully immunocompetent non-human primate

Authors: Hu, X., White, K., Young, C., Deuse, T., Schrepfer, S.

Journal: Cell Stem Cell

Year: 2024

Hypoimmune induced pluripotent stem cells survive long term in fully immunocompetent, allogeneic rhesus macaques

Authors: Hu, X., White, K., Olroyd, A.G., Deuse, T., Schrepfer, S.

Journal: Nature Biotechnology

Year: 2024

Hypoimmune anti-CD19 chimeric antigen receptor T cells provide lasting tumor control in fully immunocompetent allogeneic humanized mice

Authors: Hu, X., Manner, K., DeJesus, R., Foster, A.E., Schrepfer, S.

Journal: Nature Communications

Year: 2023

Synthetic immune checkpoint engagers protect HLA-deficient iPSCs and derivatives from innate immune cell cytotoxicity

Authors: Gravina, A., Tediashvili, G., Zheng, Y., Schrepfer, S., Deuse, T.

Journal: Cell Stem Cell

Year: 2023

Mrs. Min Xu | Pharmaceutical Chemistry | Best Researcher Award

Posted on by sciencefather

Mrs. Min Xu | Pharmaceutical Chemistry | Best Researcher Award

Mrs. Min Xu | Kunming University of Science and Technology | China

Min Xu is a distinguished researcher in the field of natural product chemistry and chemical biology, serving as a professor at Kunming University of Technology and Science (KUTS) in China. She has garnered significant recognition for her interdisciplinary work in discovering active natural molecules from Southwest ethnic medicine.

Professional Profile

Orcid

🎓 Education and Academic Journey

Min Xu has pursued a commendable academic path marked by excellence and dedication. She earned her Ph.D. in Phytochemistry from the Kunming Institute of Botany, CAS, in 2007. Her undergraduate studies culminated in a Bachelor of Science in Traditional Chinese Medicine from the Yunnan College of Traditional Chinese Medicine in 1999. These academic foundations have profoundly shaped her research focus in natural product chemistry and chemical biology.

🔬 Research Major and Interests

Min Xu is a dedicated researcher specializing in natural product chemistry, seamlessly integrating it with chemical biology to address significant scientific challenges. Her work focuses on discovering and identifying active natural molecules from Southwest ethnic medicine, an area rich in medicinal biodiversity. She is deeply involved in optimizing the structure-activity relationship of these compounds for novel probe development and assembly. A key aspect of her research is the discovery of innovative leading compounds and their mechanisms of action, particularly in addressing major diseases such as tumors, infectious diseases, and aging-related disorders. This interdisciplinary approach highlights her commitment to advancing health sciences through the potential of nature-derived compounds.

🏆 Academic Honors and Achievements

Min Xu’s groundbreaking contributions have been recognized with several prestigious honors. In 2016, she was named a Young Academic Leader of Yunnan Province, a testament to her leadership in the scientific community. She was also honored by the Talents of West Light Foundation of the Chinese Academy of Sciences in 2012. Earlier in her career, she received the West China Excellent Graduate Students Prize in 2001 from CAS and the Excellent Undergraduate Students Prize in 1999 from Yunnan College of Traditional Chinese Medicine. These accolades underscore her pioneering work and academic excellence in natural product chemistry.

💼 Professional Experience

Min Xu has held various prominent roles throughout her career, contributing significantly to academia and research. Since 2016, she has been a Professor at the Kunming University of Technology and Science (KUTS), where she continues to drive innovative research. Previously, she served as an Associate Professor at the Kunming Institute of Botany (CAS) from 2011 to 2015 and as an Assistant Researcher at the State Key Laboratory of Phytochemistry and Plant Resources in West China from 2007 to 2010. Her international experience includes a position as a Research Fellow at the Eskitis Institute for Cell and Molecular Therapies, Griffith University, Australia, from 2008 to 2009. These roles have enabled her to pioneer transformative research and mentor emerging leaders in the field.

💰 Grants and Funding Awards

Min Xu has successfully secured over 20 grants, showcasing her ability to attract significant funding for impactful research. Notable awards include a 16-million RMB grant for advancing the resources of Southwest ethnic medicine and developing treatments for hepatitis B (2023–2026). She also received a 600,000 RMB grant for her work in chemical biology under the Program for Innovative Research Team in University of Yunnan Province (2019–2022). Another remarkable project involved a 4.2-million RMB grant focused on the investigation and development of aromatic plants in Yunnan (2016–2019). These successes highlight her capacity for leading transformative research initiatives and her vision for pharmaceutical advancements.

🌱 Research Contributions and Experiences

Min Xu has consistently pushed the boundaries of natural product chemistry through her extensive research experiences. Her studies have yielded key discoveries, such as the antiviral terpenes from the Euphorbiaceae family, antifungal compounds from the genus Piper, and anti-hepatitis B virus sesquiterpenoids. Her interdisciplinary methods—ranging from compound assembly to mechanism analysis—have propelled advancements in pharmaceutical sciences. These contributions underscore her significant role in bridging natural product chemistry with therapeutic innovation.

🧪 Innovative Research Interests

Min Xu’s current research focuses on the efficient discovery and identification of bioactive natural products, with a special emphasis on Southwest ethnic medicine. Her work encompasses chemical probe development and the discovery of novel treatments for major diseases such as tumors and infectious ailments. Her approach not only enhances our understanding of medicinal chemistry but also paves the way for innovative solutions to global health challenges.

Publications Top Noted📚

Ramifloraolides A − D, four highly oxygenated picrotoxane-type sesquiterpenoids from the stems of Baccaurea ramiflora and their antithrombotic activity

Authors: Li-Hua Su, Wei Wang, Ya-Lin Yang, Min-Rong Chu, Yi-Can Wang, Hao-Hao Lv, Zi-Ang Zhou, Hao Chen, Shao-Xing Dai, Min Xu

Journal: Bioorganic Chemistry

Year: 2024

Lappanolides A−N, fourteen undescribed sesquiterpenoids from Saussurea costus (Syn. Saussurea lappa) and their anti-HBV activity

Authors: Hong-Bo Li, Shi-Qun Bai, Teng-Yun Shu, Qiong Wang, Hao Chen, Li-Hua Su, Min Xu

Journal: Phytochemistry

Year: 2024

Tsaokoflavanols A1–J1: Flavanol-fatty alcohol hybrids with HPL inhibitory activity from Amomum tsao-ko

Authors: Tian-Rong Yang, Shi-Chao Huang, Yun-Fen Wang, Zai-Xiang Lou, Shao-Xing Dai, Li-Hua Su, Min Xu

Journal: Phytochemistry

Year: 2024

Essential oil of lemon myrtle (Backhousia citriodora) induces S-phase cell cycle arrest and apoptosis in HepG2 cells

Authors: Yun-Fen Wang, Yang Zheng, Yin-Yue Cha, Yang Feng, Shao-Xing Dai, Sanjun Zhao, Hao Chen, Min Xu

Journal: Journal of Ethnopharmacology

Year: 2023

Thiol–Chromene “Click” Reaction-Activated Chemiluminescent Probe for Thiol Detection In Vitro and In Vivo

Authors: Baoqu Wang, Xiaoxue Tian, Xing-Cong Li, Kui Cheng, Min Xu

Journal: ACS Applied Materials & Interfaces

Year: 2023

Mrs. Kathrin Schön, Pharmaceutical Chemistry, Best Researcher Award

Posted on by sciencefather

Mrs. Kathrin Schön, Pharmaceutical Chemistry, Best Researcher Award

Mrs. Kathrin Schön, CSL Behring Innovation GmbH, Marburg, Germany, Germany

Profile

Orcid

Summary 📋

Dr. Kathrin Schön is a dedicated medical professional specializing in human genetics. With extensive experience in genetic counseling, molecular genetics, and cytogenetic analysis, she combines her clinical expertise with a robust research background in pharmacology and toxicology.

Education 🎓

Medicine (10/2013 – 11/2021), Philipps University Marburg
Licence to practise medicine on December 08, 2021

MD Thesis (03/2018 – ongoing), CSL Behring Innovation GmbH, Marburg
“Characterization of rFIX fusion proteins enabling subcutaneous administration”

Professional Experience 🏥

Physician in Human Genetics (since 07/2023), IMD Humangenetik Wiesbaden

Genetic counseling, examination, molecular genetic analysis, and cytogenetic laboratory work

Medical Affairs Trainee (10/2022 – 04/2023), Dr. Reiner Rittinghausen GmbH

Account management and sales

Physician (01/2022 – 08/2022), Local Health Department′s Coronavirus Faculty, Marburg

Consultant (01/2020 – ongoing), Clinical Development, CSL Behring Innovation GmbH

MD Thesis Doctoral Student (03/2018 – ongoing), CSL Behring Innovation GmbH, Marburg

Research Interests 🔬

Human Genetics: Genetic counseling and molecular genetic analysis

Pharmacology & Toxicology: Characterization of recombinant Factor IX fusion proteins

Hematology and Oncology: Clinical studies and patient care in hematology and oncology

Publications📚

Characterization of recombinant Factor IX fusion proteins enabling subcutaneous administration

Authors: Kathrin Schön, Sabine Pestel, Julia Riedesel, Waltraud Seyfert-Brandt, Philipp Claar, Eva Herzog, Alireza Rezvani-Sharif, Padmapriya Ponnuswamy, Marc W. Nolte

Journal: Journal of Thrombosis and Haemostasis

Year: 2024

Patient‐physician interactions in hereditary angioedema—Key learnings from the coronavirus disease 2019 pandemic

Authors: Maurer M, Buttgereit T, Magerl M, Schön K, Balla Z, Farkas H

Journal: Clinical and Translational Allergy

Year: 2023

Conference Poster: Characterization of rFIX fusion proteins enabling subcutaneous administration

Authors: Kathrin Schön, J. Riedesel, W. Seyfert-Brandt, S. Pestel, M. Mischnik, W. Azar, W. Hardy, M.W. Nolte, P. Claar

Journal: 65th Annual Meeting of the Society of Thrombosis and Hemostasis Research

Year: 2021